Arkolith/Insider Trading/MLTX/Form 4

Reich Kristian

Chief Scientific OfficerMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.9M
Net Open-Market Flow
-$2.9M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Sell(S)50K$19.43$972K2.8M
Jun 16, 2026Sell(S)50K$18.70$935K2.9M
Jun 15, 2026Sell(S)50K$18.89$945K2.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-069753) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML